Prashant Kumar highlighted that their collaborative global culture enabled cross-regional expertise and networks to drive value creation, with insights from multiple geographies informing successful underwriting and market expansion.
An error occurred trying to play the stream. Please reload the page and try again.
Close
Prashant Kumar, based in Singapore, joined KKR in 2018 and is a Partner and the Head of the Southeast Asia Private Equity. Mr. Kumar has led a number of the firm’s investments, including Max Healthcare, JB Chemicals & Pharmaceuticals, Vini Cosmetics, and Advanta India. Prior to joining KKR, Mr. Kumar was a director and member of the investment committee at ChrysCapital, a leading India-focused private equity fund. Previously, he was with Warburg Pincus where led investments in various sectors. Prior to that, Mr. Kumar worked at Karsch Capital Management, a New York-based hedge fund, and SUN Capital, an emerging markets focused private equity firm. He began his career as a consultant with McKinsey & Company. Mr. Kumar holds a B.Tech. from the Indian Institute of Technology Delhi, a post-graduate diploma in management from the Indian Institute of Management Kolkata, and an M.B.A. from The Wharton School at the University of Pennsylvania.
